SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2006
Bayer Aktiengesellschaft
Bayer Corporation*
(Translation of registrants name into English)
Bayerwerk, Gebaeude W11
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of
Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101 (b)(1): N/A
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101 (b)(7): N/A
Indicate by check mark whether, by furnishing the information contained in this form, the
registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
If Yes is marked, indicate below the file number assigned to the registrant in connection
with Rule 12g3-2(b): N/A
* Bayer Corporation is also the name of a wholly-owned subsidiary of the registrant in the United States.
Announcement by Bayer Aktiengesellschaft, 51368 Leverkusen, Germany
Pursuant to Article 25, Paragraph 1 of the German Securities Trading Act (WpHG)
The Capital Group Companies, Inc., 333 South Hope Street, Los Angeles, CA-90071, U.S.A., has
notified us pursuant to Article 21, Paragraph 1 of the German Securities Trading Act (WpHG) that
the proportion of voting rights it holds in our company was below the 5% threshold on February 1,
2006, that since that date it has held 4.9363 % of the voting rights, and that all of these voting
rights are attributable to it pursuant to Article 22, Paragraph 1, Sentence 1, No. 6 in conjunction
with Article 22, Paragraph 1, Sentence 2 and Sentence 3 of the German Securities Trading Act.
Leverkusen, February 8, 2006
The Board of Management of
Bayer Aktiengesellschaft
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Bayer Aktiengesellschaft (Registrant)
|
|
|
|
By: |
/s/ ppa. Dr. Alexander Rosar |
|
|
|
Name: |
Dr. Alexander Rosar |
|
|
|
Title: |
Head of Investor Relations |
|
|
|
By: |
/s/ Dr. Armin Buchmeier |
|
|
|
Name: |
Dr. Armin Buchmeier |
|
|
|
Title: |
Senior Counsel |
|
Date:
February 15, 2006